BioSpace News Archive

BioMidwest

Wastewater Testing Labs Can Detect SARS-CoV-2 in Less Than Four Hours with New Methods

A complete workflow developed by Promega Corporation enables wastewater testing laboratories, including public health organizations, to quickly assess the health of entire communities from a single sample.

August 16, 2021
·
3 min read
Business

HDT Bio Announces Agreement With Korea’s Quratis to Co-Develop Innovative COVID-19 Vaccine in Asia

HDT Bio Corp. announced today an agreement with Korean biotech Quratis Inc. to co-develop HDT’s revolutionary COVID-19 vaccine (a next generation mRNA vaccine) for distribution in South Korea and neighboring countries.

August 16, 2021
·
3 min read
Drug Development

Virios Therapeutics CEO Highlights Novel Therapeutic Approach for Treating Fibromyalgia and Irritable Bowel Syndrome in Stock News Now Video Interview

Virios Therapeutics, Inc. announced today that Chairman and CEO, Greg Duncan, highlighted the Company’s novel combination antiviral development approach, its ongoing Phase 2b trial Fibromyalgia trial and plans for expanded pipeline programs in irritable bowel syndrome (IBS)

August 16, 2021
·
3 min read
Drug Development

Rocket Pharmaceuticals Announces FDA Lifts Clinical Hold on Danon Disease Trial of RP-A501

Rocket Pharmaceuticals, Inc. today announces that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on the Company’s Phase 1 clinical trial of RP-A501 for the treatment of Danon Disease, allowing patient enrollment to resume.

August 16, 2021
·
7 min read
FDA

Virbac Announces FDA Approval of New Cancer Treatment for Dogs Derived from Australian Rainforest Plant

Virbac announces the breakthrough drug STELFONTA ® (tigilanol tiglate injection) that has been approved by the U.S. Food and Drug Administration (FDA) as a non-surgical alternative for treating canine mast cell tumors in dogs, is now available in veterinary clinics throughout the United States .

August 16, 2021
·
5 min read
Business

Taysha Gene Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Positive pre-IND/CTA feedback obtained from several key regulatory agencies for TSHA-102 in Rett syndrome, TSHA-101 in GM2 gangliosidosis and TSHA-118 in CLN1 disease, paving the way for multiple anticipated IND/CTA filings in the second half of 2021

August 16, 2021
·
17 min read
Business

Atsena Therapeutics Appoints Linda B. Couto, PhD, as Chief Scientific OfficerDr. Couto strengthens leadership team with extensive AAV and ocular gene therapy expertise

Atsena Therapeutics today announced the appointment of Linda B. Couto, PhD, as Chief Scientific Officer (CSO).

August 16, 2021
·
3 min read
Rare Disease Genetic Testing Market: Next-generation Sequencing to Offer Lucrative Growth Opportunities

More than 7000 types of rare diseases affect more than 30 million people in the U.S. alone. Approximately 80% of the rare diseases are found to be genetic.

August 16, 2021
·
4 min read
Medical Recruitment Market: Growing shortage of skilled healthcare professionals in all worldwide locations to drive the market

Growing shortage of skilled healthcare professionals in all worldwide locations is stimulating prodigious demand for medical recruitment services.

August 16, 2021
·
4 min read
Dental Rapid Prototyping Systems Market: Rapid Prototyping 3D Printer Product Type Segment to Witness Significant Growth

Rapid prototyping (RP) is one of the applications of rapid manufacturing and a type of computer-aided technology that is capable of making physical objects directly from three-dimensional (3D) computer data by adding a layer-upon-layer

August 16, 2021
·
4 min read